fenofibrate has been researched along with Cardiac Remodeling, Ventricular in 6 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peroxisome proliferator-activated receptor (PPAR) activation may prevent cardiac hypertrophy and inhibit production of endothelin-1 (ET-1), a hypertrophic agent." | 3.72 | Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. ( Amiri, F; Diep, QN; Iglarz, M; Paradis, P; Schiffrin, EL; Touyz, RM; Viel, EC, 2003) |
| "Fenofibrate is a peroxisome proliferator-associated receptor alpha agonist (PPARα) used clinically for the management of dyslipidemia and is a myocardial fatty acid oxidation stimulator." | 1.39 | Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload. ( Arsenault, M; Couet, J; Dhahri, W; Drolet, MC; Roussel, É, 2013) |
| "Fenofibrate was used as the PPARα agonist." | 1.37 | Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart. ( Nair, RR; Purushothaman, S; Sathik, MM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Cheng, Y | 1 |
| Gu, J | 1 |
| Wang, S | 1 |
| Zhou, S | 1 |
| Wang, Y | 1 |
| Tan, Y | 1 |
| Feng, W | 1 |
| Fu, Y | 1 |
| Mellen, N | 1 |
| Cheng, R | 1 |
| Ma, J | 1 |
| Zhang, C | 1 |
| Li, Z | 1 |
| Cai, L | 1 |
| Purushothaman, S | 1 |
| Sathik, MM | 1 |
| Nair, RR | 1 |
| Dhahri, W | 1 |
| Couet, J | 1 |
| Roussel, É | 1 |
| Drolet, MC | 1 |
| Arsenault, M | 1 |
| Iglarz, M | 1 |
| Touyz, RM | 1 |
| Viel, EC | 1 |
| Paradis, P | 1 |
| Amiri, F | 1 |
| Diep, QN | 1 |
| Schiffrin, EL | 1 |
| Shiroshita-Takeshita, A | 1 |
| Brundel, BJ | 1 |
| Burstein, B | 1 |
| Leung, TK | 1 |
| Mitamura, H | 1 |
| Ogawa, S | 1 |
| Nattel, S | 1 |
| Lebrasseur, NK | 1 |
| Duhaney, TA | 1 |
| De Silva, DS | 1 |
| Cui, L | 1 |
| Ip, PC | 1 |
| Joseph, L | 1 |
| Sam, F | 1 |
6 other studies available for fenofibrate and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Topics: Animals; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2016 |
Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Topics: Aging; Animals; Azo Compounds; Blood Pressure; Body Weight; Cholesterol; Disease Models, Animal; Ene | 2011 |
Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
Topics: Animals; Aortic Valve Insufficiency; Disease Models, Animal; Fatty Acids; Fenofibrate; Hypolipidemic | 2013 |
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Desoxycorticosterone; Endothelin-1; En | 2003 |
Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
Topics: Actins; Animals; Anti-Inflammatory Agents; Atrial Fibrillation; Biomarkers; Cardiac Pacing, Artifici | 2007 |
Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Extracellular Matrix; Fenofibrate; Fibrosis; Heart; Heart Rate | 2007 |